NO20010119L - Preparater omfattende GABA-analoger og kaffein - Google Patents

Preparater omfattende GABA-analoger og kaffein

Info

Publication number
NO20010119L
NO20010119L NO20010119A NO20010119A NO20010119L NO 20010119 L NO20010119 L NO 20010119L NO 20010119 A NO20010119 A NO 20010119A NO 20010119 A NO20010119 A NO 20010119A NO 20010119 L NO20010119 L NO 20010119L
Authority
NO
Norway
Prior art keywords
caffeine
preparations
gaba analogues
gaba
analogues
Prior art date
Application number
NO20010119A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010119D0 (no
Inventor
Leslie Magnus-Miller
Catherine A Segal
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO20010119L publication Critical patent/NO20010119L/no
Publication of NO20010119D0 publication Critical patent/NO20010119D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20010119A 1998-07-09 2001-01-08 Preparater omfattende GABA-analoger og kaffein NO20010119D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9213198P 1998-07-09 1998-07-09
PCT/US1999/013670 WO2000002562A1 (en) 1998-07-09 1999-06-18 Compositions comprising gaba analogs and caffeine

Publications (2)

Publication Number Publication Date
NO20010119L true NO20010119L (no) 2001-01-08
NO20010119D0 NO20010119D0 (no) 2001-01-08

Family

ID=22231777

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010119A NO20010119D0 (no) 1998-07-09 2001-01-08 Preparater omfattende GABA-analoger og kaffein

Country Status (13)

Country Link
US (1) US6326374B1 (US07794700-20100914-C00152.png)
EP (1) EP1094817A1 (US07794700-20100914-C00152.png)
JP (1) JP2002520286A (US07794700-20100914-C00152.png)
KR (1) KR20010071777A (US07794700-20100914-C00152.png)
AU (1) AU772156B2 (US07794700-20100914-C00152.png)
BR (1) BR9911917A (US07794700-20100914-C00152.png)
CA (1) CA2332915C (US07794700-20100914-C00152.png)
ID (1) ID28277A (US07794700-20100914-C00152.png)
NO (1) NO20010119D0 (US07794700-20100914-C00152.png)
NZ (1) NZ508490A (US07794700-20100914-C00152.png)
PL (1) PL345340A1 (US07794700-20100914-C00152.png)
WO (1) WO2000002562A1 (US07794700-20100914-C00152.png)
ZA (1) ZA200007168B (US07794700-20100914-C00152.png)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9710536A (pt) 1996-07-24 1999-08-17 Warner Lambert Co Isobutilgaba e seus derivados para o tratamento da dor
US6992109B1 (en) * 1999-04-08 2006-01-31 Segal Catherine A Method for the treatment of incontinence
JP2002541215A (ja) * 1999-04-09 2002-12-03 ユーロ−セルティック エス． ア． ナトリウムチャネル遮断薬組成物およびその使用
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
NZ531586A (en) * 2001-09-03 2005-09-30 Newron Pharm Spa Pharmaceutical composition comprising gabapentin or an analogue thereof and an alpha-aminoamide and its analgesic use
ES2292107T3 (es) * 2004-03-12 2008-03-01 Warner-Lambert Company Llc Ligandos de bifosfina simetricos en c1 y su uso en la sintesis asimetrica de pregabalina.
CA2561755A1 (en) * 2004-04-01 2005-10-13 Warner-Lambert Company Llc Preparation of p-chirogenic phospholanes and their use in asymmetric synthesis
DK1831154T3 (da) * 2004-06-21 2010-04-12 Warner Lambert Co Fremstilling af pregabalin og relaterede forbindelser
PT1809271E (pt) * 2004-09-10 2010-08-30 Newron Pharm Spa Utilização de (halogenobenziloxi)benzilamino-propanamidas para o fabrico de medicamentos activos como moduladores selectivos dos canais de sódio e/ou de cálcio
RS54522B1 (en) * 2005-12-22 2016-06-30 Newron Pharmaceuticals S.P.A. 2-Phenylethylamino Derivatives as Modulators of Calcium and (or Sodium) Channels
US7645767B2 (en) * 2006-08-31 2010-01-12 Trinity Laboratories, Inc. Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
CH699327B1 (de) 2007-02-14 2010-03-15 Oerlikon Heberlein Temco Wattw Vorrichtung zum gleichzeitigen Behandeln von mehreren multifilen Fäden.
US10300031B2 (en) 2007-08-06 2019-05-28 Trinity Laboratories Inc. Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
SG176464A1 (en) 2008-05-09 2011-12-29 Agency Science Tech & Res Diagnosis and treatment of kawasaki disease
US20100190752A1 (en) * 2008-09-05 2010-07-29 Gruenenthal Gmbh Pharmaceutical Combination
WO2011141923A2 (en) 2010-05-14 2011-11-17 Lupin Limited Improved synthesis of optically pure (s) - 3-cyano-5-methyl-hexanoic acid alkyl ester, an intermediate of (s)- pregabalin
WO2012059797A1 (en) 2010-11-04 2012-05-10 Lupin Limited Process for synthesis of (s) - pregabalin

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656177A (en) * 1982-07-22 1987-04-07 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US5248678A (en) 1992-06-30 1993-09-28 Fractal Laboratories, Inc. Methods for increasing arousal and alertness and for the amelioration of comatose states
CA2170485C (en) * 1993-09-07 2000-11-07 Sekhar Mitra Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
US5443838A (en) 1993-09-15 1995-08-22 Koenig, Jr.; Steven M. Nutritional supplementation system
DK0888286T3 (da) 1996-03-14 2002-02-18 Warner Lambert Co Nye substituerede cykliske aminosyrer som farmaceutiske midler
AU4078897A (en) * 1996-08-23 1998-03-06 Algos Pharmaceutical Corporation Anticonvulsant containing composition for treating neuropathic pain
US6153650A (en) * 1996-10-23 2000-11-28 Warner-Lambert Company Substituted gamma aminobutyric acids as pharmaceutical agents
ES2253825T3 (es) 1997-09-08 2006-06-01 Warner-Lambert Company Llc Composiciones analgesicas que comprenden compuestos antiepilepticos y procedimientos para usar las mismas.

Also Published As

Publication number Publication date
US6326374B1 (en) 2001-12-04
NZ508490A (en) 2003-08-29
AU772156B2 (en) 2004-04-08
CA2332915C (en) 2006-10-24
PL345340A1 (en) 2001-12-17
BR9911917A (pt) 2001-03-27
CA2332915A1 (en) 2000-01-20
ID28277A (id) 2001-05-10
KR20010071777A (ko) 2001-07-31
EP1094817A1 (en) 2001-05-02
NO20010119D0 (no) 2001-01-08
ZA200007168B (en) 2002-03-04
WO2000002562A1 (en) 2000-01-20
JP2002520286A (ja) 2002-07-09
AU4691099A (en) 2000-02-01

Similar Documents

Publication Publication Date Title
IS5525A (is) Innúðabúnaður og aðferð
DK0921796T3 (da) Tetrahydrolipstatinholdige præparater
IS5744A (is) Nýjar 3-arýl-própíónsýruafleiður og -hliðstæður
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
NO20000700D0 (no) Interleukin-18-proteiner samt fremstilling og anvendelse derav
NO20032753L (no) Forbindelse og anvendelse derav
NO972911D0 (no) Stabiliserte ribozym-analoger
NO20010119L (no) Preparater omfattende GABA-analoger og kaffein
NO991150D0 (no) Pyrazolopyrimidiner og pyrazolotriaziner
ITMI982280A0 (it) Alcune n-(2-april-propionil)-solfonammidi e preparazioni farmaceutiche che le contengono
NO983364D0 (no) Konsensusproteiner
MA24473A1 (fr) Formulations
ATE266383T1 (de) Dermatologische zubereitungen
NO20001323D0 (no) Dipeptid-apoptose inhibitorer og deres anvendelse
NO20003312D0 (no) Gamma-glutamyl og beta-aspartyl inneholdende immunmodulator- forbindelser og fremgangsmÕter derav
NO995324L (no) Baerer for gjenstander og emne for denne
NO995683D0 (no) Vitamin D analoger og deres neuronale effekter
NO20000057L (no) Kjernerør
NO993731D0 (no) Pyrrolopyrazolopyrimidin-forbindelse og medisin omfattende denne
ITTV970086A0 (it) Struttura di pattino
DK0826679T3 (da) Naphthylforbindelser og -præparater
DK0929577T3 (da) Stabiliserede proteinholdige protease-inhibitorer og varianter deraf
EE04701B1 (et) Kihisevad preparaadid
DE69806784D1 (de) Spieldose
FI974044A0 (fi) Spis